Tramadol is one of the most prescribed pain medications in the world, but for a meaningful percentage of people, it simply doesn't provide adequate relief. Like codeine, tramadol is a prodrug that your body must convert into a more potent form (O-desmethyltramadol) to fully work. That conversion depends on CYP2D6, an enzyme with enormous genetic variability across the population.
Seek immediate medical attention if you experience seizures, difficulty breathing, extreme drowsiness, or confusion after taking tramadol. Tramadol lowers the seizure threshold and carries opioid-related respiratory risks, especially in ultrarapid metabolizers or when combined with other CNS depressants.
About 5-10% of Caucasians are CYP2D6 poor metabolizers who produce very little of tramadol's active metabolite. For these people, tramadol provides weak or no opioid-type pain relief at any dose. This is the single most common reason tramadol fails to control pain.
Tramadol works through two mechanisms: weak opioid activity and serotonin/norepinephrine reuptake inhibition. It's most effective for moderate acute pain. Severe pain, neuropathic pain, or chronic pain conditions may not respond adequately to tramadol regardless of genetics.
If you've used opioids before, you may have developed tolerance that makes tramadol's relatively mild opioid effect insufficient. Tramadol is weaker than most other opioids, so patients with prior opioid exposure often find it inadequate.
Medications that inhibit CYP2D6 (such as fluoxetine, paroxetine, bupropion, and quinidine) can reduce tramadol's conversion to its active form, mimicking the effect of being a genetic poor metabolizer. CYP3A4 inhibitors can also alter tramadol levels.
Tramadol's relationship with CYP2D6 is essentially the same as codeine's. Your body must activate the drug through this enzyme, and the speed of that activation is determined by your genes.
CYP2D6 converts tramadol into O-desmethyltramadol (M1), which has about 200 times more opioid receptor affinity than tramadol itself. Poor metabolizers produce very little M1, meaning they get almost no opioid pain relief from tramadol. Ultrarapid metabolizers produce M1 too quickly, which can cause respiratory depression and other dangerous effects.
CPIC guidelines recommend avoiding tramadol entirely for both ultrarapid metabolizers (due to toxicity risk) and poor metabolizers (due to lack of efficacy). For intermediate metabolizers, the recommendation is to use tramadol with caution and to monitor closely for reduced response. If you're a poor metabolizer, no dose increase will make tramadol work because the fundamental conversion step is impaired. You need a different pain medication entirely.
If tramadol provides no pain relief at adequate doses, pharmacogenetic testing should be near the top of your list. The same CYP2D6 result will also tell you whether codeine will work for you (it won't if you're a poor metabolizer) and whether other CYP2D6-metabolized medications may need dose adjustments. It's a single test with broad relevance across your medication profile.
Learn how genetics may affect your response to these related medications:
It depends on the opioid. Codeine has the same CYP2D6 dependency and will likely fail for the same reason. However, morphine, oxycodone, and hydrocodone work through different metabolic pathways and may be effective. Your doctor can help choose an appropriate alternative.
Yes, though a weak one. Tramadol itself has very low opioid receptor affinity. Its opioid pain relief comes primarily from its active metabolite (O-desmethyltramadol), which is why CYP2D6 metabolism is so critical. Tramadol also has non-opioid analgesic properties through serotonin and norepinephrine reuptake inhibition.
Yes. Ultrarapid metabolizers convert tramadol to its active form too quickly, which can cause respiratory depression, excessive sedation, and in severe cases, death. CPIC guidelines recommend avoiding tramadol entirely for ultrarapid metabolizers, similar to the warning for codeine.
Find out how your DNA may influence your response to Tramadol and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator